Role Of Multidetector CT in Evaluation of Benign Focal Liver Lesions in a Tertiary Care Centre in North India
PDF

Keywords

Multidetector CT
Focal liver lesions

How to Cite

1.
Narang T, Shweta, Gathwal C, Shailley. Role Of Multidetector CT in Evaluation of Benign Focal Liver Lesions in a Tertiary Care Centre in North India. Integr J Med Sci [Internet]. 2020Dec.21 [cited 2021Feb.25];8. Available from: https://mbmj.org/index.php/ijms/article/view/340

Abstract

Introduction: Introduction of Multi Detector computed Tomography has been a huge leap in the CT technology. MDCT has a high diagnostic accuracy, sensitivity and specificity in the evaluation of focal and diffuse lesions of liver. The present study aimed to study the role of MDCT as a diagnostic modality for the benign lesions of liver. Material and methods: A prospective study of the role of MDCT in detecting and characterizing neoplastic hepatic lesions was conducted in the period in radiology department of RMCH, Bareilly. Thirty patients, with hepatic benign lesions, were selected. Diagnosis was confirmed by surgery and histopathology, follow up imaging and other non-radiological investigations. Results: Thirty patients were finally included as they were found to have benign lesions. Mean age of the patients was 49.8 years. 37% patients aged between 41 and 50 years while 17% patients were elderly. 63% were females. 63% patients had alcohol abuse while 60% were smokers. The most common presenting complaint was pain abdomen (n=15) followed by abdominal discomfort (n=13). Total of 29 lesions were identified on MDCT. The most common lesions were hemangioma (n=15)  followed by simple cyst (n=5). Conclusion: MDCT is “The Imaging Modality of choice” in characterizing benign hepatic lesions.

https://doi.org/10.15342/ijms.2021.340
PDF

References

1. Hussain SM, Semelka RC. Hepatic Imaging:Comparison of modalities Radiol Clin North Am43.(2005) sep ; 43(5)929 – 47 .
[2] Berland LL, Smith JK. Multi-detector array CT: once again, technology creates new opportunities (editorial). Radiology. 1998;20(9):327-29.
[3] Bonaldi VM, Bret PM, Reinhold C, Atri M. Helical computed tomogram of liver, value of an early hepatic arterial phase. Radiology. 1995;19(7):357-63.
[4] Francis IR, Cohan RH, McNulty NJ, Platt JF, Korobkin M, Gebremariam A, et al. Multi-detector CT of the liver and hepatic neoplasms: Effect of multiphasic imaging on tumor conspicuity and vascular enhancement. AJR Am J Roentgenol.

2003;18(1):1217-24.

[5] Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, et al. Detection and characterization of focal liver lesions: A Japanese phase III, multicenter
comparison between gadoxetic acid disodium enhanced magnetic resonance imaging and contrast enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol. 2010;4(5):133-41.
[6] Hammersting R, Huppertz A, Breuer J, Balzer T, Blakeborough A, Carter R, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: Comparison with Intraoperative and histopathologic findings in focal liver lesions. Eur Radiol. 2008;1(8):457-67.
[7] Soyer P, Sirol M, Fargeaudou Y, Duchat F, Hamzi L, Boudiaf M, et al. Differentiation between true focal liver lesions and pseudolesions in patients with fatty liver:
evaluation of helical CT criteria. Eur Radiol. 2010;20(1):1726-37.

[8] Van Leeuven MS, Noordzij J, Feldberg MA, Hennipman AH, Doorneewaard

H. Focal Liver lesions; characterization with tri-phasic computed tomography.

Radiology. 1996;20(1):327-36.

[9] Szklaruk J, Silverman PM, Chamsangavej C. Imaging in the diagnosis, staging, treatment and surveillance of hepatocellular carcinoma. AJR Am J Roentgenol. 2003;18(1):441-54.
[10] Iannaccone R, Piacentini F, Murakami T, Paradis V, Belghiti J, Hori M, et al.

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: Helical CT and MR imaging findings with clinical-pathologic comparison. Radiology.
2007;24(3):422-30.

[11] Tyagi V, Sahoo K, Shaha P, Tyagi N, Thite H, Aggarwal D, et al. Evaluation of liver masses with 16 slice multi-detector computed tomography with pathological
correlation. JMSCR. 2018;06(01):32033-45.

[12] Kalpesh K. Patel, Mayur V. Khandhedia, Vishalkumar H. Bhardava. Multi-detector CT evaluation of liver neoplasms. International Journal of Contemporary Medicine Surgery and Radiology. 2018;3(3):C158-C163
[13] Horton, K. M., Bluemke, D. A., Hruban, R. H., Soyer, P., and Fishman, E. K. CT and MR Imaging of Benign Hepatic and Biliary Tumors. RadioGraphics, 1999; 19(2): 431–451.
[14]. Mathieu, D., Vilgrain, V., Mahfouz, A. E., Anglade, M. C., Vullierme, M. P., and Denys, A. Benign liver tumors. Magnetic Resonance Imaging Clinics of North America 1997;5(2):255–288
[15] Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am 1975; 59:995-1013. [16]. Brannigan M, Burns PN, Wilson SR. Blood flow patterns in focal liver lesions at microbubble-enhanced US. RadioGraphics 2004; 24(3):921-935.
[17] Soyer, P., Dufresne, A. C., Somveille, E., and Scherrer, A. Hepatic cavernous hemangioma: Appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression. AJR Am J Roentgenol. 1997;168(2):461-5.
[18] Nelson RC, Chezmar JL. Diagnostic approach to hepatic hemangiomas. Radiology 1990; 176(3):11-13.
[19] Leslie DF, Johnson CD, MacCarty RL, Ward EM, Ilstrup DM, Harmsen WS. Single- pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases. Am J Roentgenol 1995; 165(5):1403-1406.
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2020 Narang T et al.